Differential cytokine regulation by NF-κB and AP-1 in Jurkat T-cells

BackgroundActivator protein (AP)-1 and nuclear factor (NF)-κB largely control T-cell activation, following binding of foreign antigens to the T-cell receptor leading to cytokine secretion. Elevated levels of pro-inflammatory cytokines and chemokines such as TNF, IL-6 and CXCL8 are associated with several human diseases including cystic fibrosis, pulmonary fibrosis and AIDS. The aim of this study was to investigate the role of the transcription factors, AP-1 and NF-κB, in IL-6 and CXCL8 regulation in Jurkat T-cells.ResultsPhorbol myristate acetate (PMA) exposure resulted in an up-regulation of AP-1 and down-regulation of NF-κB activity, however, exposure to heat killed (HK) Escherichia. coli MG1655 resulted in a dose-dependent increase in NF-κB activity without affecting AP-1. The cytokine profile revealed an up-regulation of the chemokine CXCL8 and the pro-inflammatory cytokines TNF, IL-2 and IL-6 following treatment with both PMA and HK E. coli, while the levels of the anti-inflammatory cytokine IL-10 were not affected by PMA but were significantly down-regulated by HK E. coli. AP-1 activation was significantly increased 2 h after PMA exposure and continued to increase thereafter. In contrast, NF-κB responded to PMA exposure by a rapid up-regulation followed by a subsequent down-regulation. Increased intracellular Ca2+ concentrations countered the down-regulation of NF-κB by PMA, while similar treatment with calcium ionophore resulted in a reduced NF-κB activity following induction with HK E. coli. In order to further study NF-κB activation, we considered two up-stream signalling proteins, PKC and Bcl10. Phosphorylated-PKC levels increased in response to PMA and HK E. coli, while Bcl10 levels significantly decreased following PMA treatment. Using an NF-κB activation inhibitor, we observed complete inhibition of IL-6 expression while CXCL8 levels only decreased by 40% at the highest concentration. Treatment of Jurkat T-cells with PMA in the presence of JNK-inhibitor suppressed both CXCL8 and IL-6 while PKC-inhibitor primarily decreased CXCL8 expression.ConclusionThe present study shows that NF-κB regulated IL-6 but not CXCL8. This complex regulation of CXCL8 suggests that there is a need to further evaluate the signalling pathways in order to develop new treatment for diseases with elevated CXCL8 levels, such as AIDS and autoimmune diseases.

[1]  A. Bassuk,et al.  A direct physical association between ETS and AP-1 transcription factors in normal human T cells. , 1995, Immunity.

[2]  J. Christman,et al.  Dysregulated Cytokine Production in Human Cystic Fibrosis Bronchial Epithelial Cells , 2001, Inflammation.

[3]  R. Pacifici,et al.  Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  V. Tergaonkar.  NFkappaB pathway: a good signaling paradigm and therapeutic target. , 2006, The international journal of biochemistry & cell biology.

[5]  T. Seemungal,et al.  Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels , 2000, Thrombosis and Haemostasis.

[6]  Jürgen Ruland,et al.  Transducing signals from antigen receptors to nuclear factor κB , 2003, Immunological reviews.

[7]  Thomas Gebhardt,et al.  Role of activator protein 1, nuclear factor-kappaB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells. , 2003, The Journal of allergy and clinical immunology.

[8]  L. Scorrano,et al.  Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-κB and NFAT , 2001, Nature Immunology.

[9]  T. Hirano,et al.  IL-6 in autoimmune disease and chronic inflammatory proliferative disease. , 2002, Cytokine & growth factor reviews.

[10]  G. Beall,et al.  Infection with HIV is associated with elevated IL-6 levels and production. , 1990, Journal of immunology.

[11]  M. Ginn-Pease,et al.  Optimal NF kappa B mediated transcriptional responses in Jurkat T cells exposed to oxidative stress are dependent on intracellular glutathione and costimulatory signals. , 1996, Biochemical and biophysical research communications.

[12]  R. Ye,et al.  Differential roles of PKC-theta in the regulation of intracellular calcium concentration in primary T cells. , 2006, Journal of molecular biology.

[13]  M. Gorospe,et al.  Control of gene expression during T cell activation: alternate regulation of mRNA transcription and mRNA stability , 2005, BMC Genomics.

[14]  T. Standiford,et al.  Interleukin-8: a major mediator of acute pulmonary inflammation. , 1993, Regional immunology.

[15]  J. W. Rooney,et al.  Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. , 1995, Immunity.

[16]  E. Verdin,et al.  Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors. , 1998, Journal of immunology.

[17]  S. Makarov.  NF-κB as a therapeutic target in chronic inflammation: recent advances , 2000 .

[18]  I. Adcock,et al.  NF-kappa B: a pivotal role in asthma and a new target for therapy. , 1997, Trends in pharmacological sciences.

[19]  A. Rao,et al.  Partners in transcription: NFAT and AP-1 , 2001, Oncogene.

[20]  V. L. Johnson,et al.  MAPK/ERK signaling in activated T cells inhibits CD95/Fas‐mediated apoptosis downstream of DISC assembly , 2000, The EMBO journal.

[21]  M. Bina,et al.  Organization of the promoter region of the human NF-IL6 gene. , 2002, Biochimica et biophysica acta.

[22]  Xavier Matias-Guiu,et al.  NF-kB in development and progression of human cancer , 2005, Virchows Archiv.

[23]  A. Rao,et al.  The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter , 1992, The Journal of experimental medicine.

[24]  S. Opal,et al.  Anti-inflammatory cytokines. , 2000, Chest.

[25]  W. Yoon,et al.  Sustained activation of protein kinase C downregulates nuclear factor-kappaB signaling by dissociation of IKK-gamma and Hsp90 complex in human colonic epithelial cells. , 2007, Carcinogenesis.

[26]  H. Tilg,et al.  Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. , 1994, Blood.

[27]  J. C. Pratt,et al.  The Small GTP-Binding Protein Rho Potentiates AP-1 Transcription in T Cells , 1998, Molecular and Cellular Biology.

[28]  N. Rice,et al.  Expression of NFAT-family proteins in normal human T cells , 1997, Molecular and cellular biology.

[29]  A. Rao,et al.  Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling. , 2004, Molecular and cellular biology.

[30]  A. Weiss,et al.  Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines , 2001, Nature Immunology.

[31]  K. Yasumoto,et al.  Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. , 1992, The Journal of biological chemistry.

[32]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[33]  J. Avruch,et al.  Sounding the Alarm: Protein Kinase Cascades Activated by Stress and Inflammation* , 1996, The Journal of Biological Chemistry.

[34]  Giovanna E Carpagnano,et al.  Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[35]  P. Blumberg,et al.  RasGRP links T-cell receptor signaling to Ras. , 2000, Blood.

[36]  I. Adcock,et al.  NF-kB: a pivotal role in asthma and a new target for therapy , 1997 .

[37]  Terry J. Smith,et al.  Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. , 1997, The American journal of pathology.

[38]  I. Screpanti,et al.  Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements , 1992, The Journal of experimental medicine.

[39]  A. Tordai,et al.  Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes. , 1994, The Journal of clinical investigation.

[40]  Vinay Tergaonkar,et al.  NFκB pathway: A good signaling paradigm and therapeutic target , 2006 .

[41]  Roger S Smith,et al.  15-Deoxy-Δ12,1412,14-PGJ2 Induces IL-8 Production in Human T Cells by a Mitogen-Activated Protein Kinase Pathway1 , 2002, The Journal of Immunology.

[42]  C. Dinarello,et al.  Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. , 1997, Chest.

[43]  K. Yasumoto,et al.  The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. , 1994, The Journal of biological chemistry.

[44]  Jun Wang,et al.  A role for Ets1, synergizing with AP-1 and GATA-3 in the regulation of IL-5 transcription in mouse Th2 lymphocytes. , 2006, International immunology.

[45]  M. Cybulsky,et al.  Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. , 1996, The Journal of clinical investigation.

[46]  P. Davis,et al.  Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[47]  Minho Won,et al.  Sustained activation of protein kinase C downregulates nuclear factor-κB signaling by dissociation of IKK-γ and Hsp90 complex in human colonic epithelial cells , 2007 .

[48]  S. Foster,et al.  Peptidoglycan and Lipoteichoic Acid from Staphylococcus aureus Induce Tumor Necrosis Factor Alpha, Interleukin 6 (IL-6), and IL-10 Production in Both T Cells and Monocytes in a Human Whole Blood Model , 2000, Infection and Immunity.

[49]  C. Y. Wang,et al.  The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB , 1993, Molecular and cellular biology.

[50]  U. Siebenlist,et al.  Activation of nuclear factor-kappaB via T cell receptor requires a Raf kinase and Ca2+ influx. Functional synergy between Raf and calcineurin. , 1996, Journal of immunology.

[51]  J. D. de Vries,et al.  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells , 1996, The Journal of experimental medicine.

[52]  A. Rao,et al.  Degradation of Bcl10 Induced by T-Cell Activation Negatively Regulates NF-κB Signaling , 2004, Molecular and Cellular Biology.

[53]  L. Kane,et al.  CARMA1 is required for Akt-mediated NF-kappaB activation in T cells. , 2006, Molecular and cellular biology.

[54]  S. Makarov.  NF-kappaB as a therapeutic target in chronic inflammation: recent advances. , 2000, Molecular medicine today.

[55]  L. Heasley,et al.  JNK regulation of oncogenesis. , 2006, Molecules and cells.

[56]  Y. Nishizuka,et al.  Protein kinase C and T cell activation. , 1990, European journal of biochemistry.

[57]  L. Kane,et al.  CARMA1 Is Required for Akt-Mediated NF-κB Activation in T Cells , 2006, Molecular and Cellular Biology.

[58]  T. Grundström,et al.  Regulation of c-Rel Nuclear Localization by Binding of Ca2+/Calmodulin , 2003, Molecular and Cellular Biology.

[59]  A. Rao,et al.  Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp , 1996, Molecular and cellular biology.

[60]  B. Graf,et al.  Fibroblasts as sentinel cells: role of the CDcd40-CDcd40 ligand system in fibroblast activation and lung inflammation and fibrosis. , 2001, Chest.

[61]  G. Franzoso,et al.  Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. , 1993, Proceedings of the National Academy of Sciences of the United States of America.